TITLE

Splenic vein thrombosis diagnosis clouded by concurrent metastatic liver disease

AUTHOR(S)
Hayashi, Paul H; Kugelmas, Marcelo
PUB. DATE
September 2003
SOURCE
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS214
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Splenic Vein Thrombosis Diagnosis Clouded by Concurrent Metastatic Liver Disease" by Paul H. Hayashi and Marcelo Kugelmas is presented.
ACCESSION #
66954864

 

Related Articles

  • Aetiology of extrahepatic portal vein thrombosis. Spanier, B.W.M.; Frederiks, J. // Gut;Nov2002, Vol. 51 Issue 5, p756 

    Comments on a paper published in a previous issue of the periodical 'Gut,' which described the etiology and determinants of survival of extrahepatic portal vein thrombosis.

  • Author's reply. Janssen, H.L.A. // Gut;Nov2002, Vol. 51 Issue 5, p756 

    Presents the author's reaction to a reader's comments about his paper published in a previous issue of the periodical 'Gut,' which described the etiology and determinants of survival of extrahepatic portal vein thrombosis. Clarification of various points made by the reader.

  • Portal vein thrombosis in the adult: Surgical implications... Alam, Hasan; Kim, Donald // American Surgeon;Aug1997, Vol. 63 Issue 8, p681 

    Presents a study on extrahepatic portal vein thrombosis (EHPVT) as leading cause of variceal hemorrhage in patients with healthy liver. Methodology used in the study; EHPVT surgical implication in an era of dynamic imaging; Etiological factors for portal vein thrombosis; Results of the study;...

  • Tissue Factor Pathway Inhibitor Concentrations in Cirrhotic Patients with and without Portal Vein Thrombosis. Öksüzoglu, Gürol; Simsek, Halis; Haznedaroglu, Ibrahim C.; Kirazli, Serafettin // American Journal of Gastroenterology;Feb1997, Vol. 92 Issue 2, p303 

    Objectives: Our aim was to determine whether tissue factor pathway inhibitor (TFPI), a physiologically important natural anticoagulant that acts by inhibiting the extrinsic pathway, concentrations decrease as liver disease progresses, and, second, whether TFPI has an etilogic role in portal vein...

  • A 25-year clinical history of portopulmonary hypertension associated with latent myeloproliferative disorder. Ito, Hideto; Adachi, Yasushi; Arimura, Yoshiaki; Endo, Takao; Hinoda, Yuji; Imai, Kohzo // Journal of Gastroenterology;2003, Vol. 38 Issue 5, p488 

    Pulmonary hypertension associated with increased pulmonary vascular resistance occurring in the setting of portal hypertension, referred to as "portopulmonary hypertension", is a complication of chronic liver disease, and occurs in 2% to 3% of patients with portal hypertension. Portal...

  • Hepatopatía crónica: sangrado vs. trombosis. Aristizábal Henao, Natalia; Madrid Muñoz, Camilo Alberto; Restrepo Gutiérrez, Juan Carlos // Revista Colombiana de Gastroenterología;Oct2011, Vol. 26 Issue 4, p285 

    Coagulation alterations in patients with chronic liver disease occur frequently, although they are usually described as auto-anticoagulation phenomena. Changes in hemostasis are broad and diffuse. They include changes in procoagulant and anticoagulant substances, hemodynamic modifi cations,...

  • Selective Portal Vein Clamping for Radiofrequency Ablation of Hepatocellular Carcinoma With Portal Vein Invasion Chok, Kenneth S.; Ng, Kenneth C.; Lam, Chi Ming; Ng, Kelvin K.; Poon, Ronnie T.; Fan, Sheung Tat // Journal of Gastrointestinal Surgery;Apr2005, Vol. 9 Issue 4, p489 

    Surgical resection provides potential cure for patients with hepatocellular carcinoma. Unfortunately, resection is suitable in only about 10–37% of patients because of the limited hepatic functional reserve from the underlying chronic liver disease in the majority of patients. Survival of...

  • AASLD updates guidelines for genotype 1 chronic HCV.  // PharmacoEconomics & Outcomes News;10/15/2011, Issue 639, p3 

    This section offers medical-related news briefs. The American Association for the Study of Liver Diseases (AASLD) has released an updated practice guidelines for genotype 1 chronic hepatitis C virus (HCV) infection management. The American Academy of Orthopaedic Surgeons (AAOS) published...

  • Changing spectrum of Budd-Chiari syndrome in India with special reference to non-surgical treatment. Amarapurkar, Deepak N.; Punamiya, Sundeep J.; Patel, Nikhil D. // World Journal of Gastroenterology;1/14/2008, Vol. 14 Issue 2, p278 

    AIM: To evaluate patterns of obstruction, etiological spectrum and non-surgical treatment in patients with Budd-Chiari syndrome in India. METHODS: Forty-nine consecutive cases of Budd-Chiari syndrome (BCS) were prospectively evaluated. All patients with refractory ascites or deteriorating liver...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics